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INTRODUCTION 
Dyspepsia is affecting about 25% of general population in developed 
nations and it is a major cause for medical visits. New patients comprise 
about 10% of population every year. Dyspepsia majorly affects quality of 
life and it is a major burden in view of social costs. Directly the expenses are 
for laboratory tests, medical consultation and drugs and indirectly by 
absence from work. 
Dyspepsia refers to spectrum of diseases and heterogeneous group of 
symptoms confined to upper abdomen.  Dyspepsia is a vague term used to 
explain upper abdominal collection of symptoms like indigestion, fullness, 
early satiety (not able to complete the meals), bloating, belching, nausea, 
epigastric discomfort or pain and anorexia. Indigestion is very common in 
general population; almost all have had indigestion at some time in their 
lifetime. Sometimes patients will include constipation and undigested food 
particles in the stool. 
Rome II working team defined dyspepsia as discomfort or pain in 
upper abdomen. Central abdominal pain is considered to be a vital symptom. 
Pain which is present in other regions or associated to defecation is not 
considered. 
Non ulcer dyspepsia, this description comprises a group of symptom 
complex simulating peptic ulcer in patients who have no provable or 
objective evidence of an ulcer. Based on analysis of problems individuals 
with non ulcer dyspepsia categorized into two types. 
2 
 
Pseudo ulcer syndrome—with classic symptoms of ulcer disease 
Functional dyspepsia—with post prandial fullness, belching and 
bloating, occasionally associated with pyloroduodenal irritability and 
prolonged gastric emptying. Usually this functional component is attributed 
to uncoordinated motor activity and afferent hyper reactivity.  
Gastro-oesophageal reflux disease is a condition, defined as abnormal 
entering of gastric juice into oesophagus and causes symptoms due to tissue 
damage. The principal pathophysiological problem is the presence of 
unusual amount of gastric juice in the lumen of oesophagus. Symptoms 
thought to suggest of gastro-oesophageal disease , such as heart burn or 
regurgitation are very much prevalent in general population and many 
individuals do not seek medical advice. The presence of symptoms doesn’t 
correlate well with the tissue damage. For instance the significant problem 
like Barrett’s oesophgus, even in early adenocarcinoma, can occur without 
symptoms. 
Gastro-oesophageal reflux disease is most commonly treated by 
physicians, this is substantiated by amount of revenue recorded by many 
pharmacteutical company. The symptoms are due to failure of protective 
antireflux mechanisms. A clear understanding of the normal anatomy and 
physiology of esophagus is mandatory to decide the surgical and medical 
management. 
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OBJECTIVES 
 
1. To study the endoscopic presentation of dyspepsia. 
2. Early detection of esophagogastroduodenal carcinoma. 
3. To study the age and sex prevalence in patients presenting with 
dyspepsia. 
4. To study the common site of lesion in patients presenting with 
dyspepsia. 
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REVIEW OF LITERATURE 
         Epidemiology is the study of the distribution and determinants of 
disease and damage in human populations. So there are 2 phases, one 
descriptive ascertaining population with high and low incidence of known 
disease and the other analytical which determines the reason for imbalanced 
distribution. In the case of dyspepsia, the hope is that epidemiological 
research will lead to cause of the condition. The dyspepsia, the clinical 
syndrome will have different causative factors in different persons. The 
reasons for a particular person in same group developing dyspepsia are 
probably complex and comprise genetic, environmental and psychological 
factors.  
      Major changes have happened in the tests and procedures available for 
the evaluation of dyspepsia patients in the last 40 years. With barium meal 
examination, it was difficult to examine the duodenum and to discriminate 
between active ulceration and healed one. With the advent of upper 
gastrointestinal endoscope it is possible to diagnose disease accurately, both 
acute and scarring, in both stomach and duodenum. 
      Environmental reasons play major role in pathogenesis of peptic ulcer 
and its inconsistent frequency.  
          Chadwick P et al. evaluated 342 dyspeptic patients. Only 19% of 
patients found to be having significant findings in endoscopy. The clinical 
symptoms elicited in the history including the ominous symptoms and signs 
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did not correlate with the endoscopic findings. In 23% patients, biopsies 
proved the presence of H. pylori infection. The infection too did not correlate 
well the significant findings in endoscopy. So they came to the conclusion 
that patients with dyspepsia had only few significant findings in endoscopy. 
The presence of these lesions could not be reliably predicted using clinical 
data and H. pylori infection status. Finally the empirical anti ulcer treatment 
advised as the initial therapy before consideration of endoscopy in majority 
of patients.          
Herring J et al. Studied 60 patients with dyspepsia by endoscopy. In 
those 60 patients, 70% were males while 30% were females.  82% of 
patients were in the age group of 30-50 years. The most common symptoms 
were epigastric pain in 90% of cases, heartburn in 72% and flatulence in 
70% cases. The findings in oesophago duodenoscopy were normal in 50% 
patients. The findings included esophagitis in 12% of patients, gastric ulcer 
in 10% of patients, duodenal ulcer in 8% of patients, gastritis in 8% of 
patients and  duodenitis in 4% of patients; while esophagogastritis ,  
esophagogastroduodenitis and carcinoma stomach were present in 2% of 
patients each.  Histopathological examination done for all the atypical 
findings and confirmed. The conclusion was that in most of the patients with 
dyspepsia, the endoscopic findings were found to be normal. The frequent 
abnormal findings in endoscopy were esophagitis, gastric ulcer, duodenal 
ulcer and gastritis.  The findings corroborated with biopsy results. 
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Thomson A B R et al. did endoscopy in 1040 adult patients presented 
with unevaluated dyspepsia within 10 days of referral. Clinically significant 
findings  were made out in 58% (603/1040) of patients. Esophagitis was the 
most identified finding (43%) and peptic ulcer was found to be the least 
(5.3%). Many  patients had minimum 3 dyspepsia symptoms, almost 80% 
had  six symptoms, and 50% had more than 8 symptoms. According to the 
predominent symptom, 463 (45%) patients had ulcer-type, 393 (38%) had 
reflux-type and 184 (18%) had dysmotility-type dyspepsia. The patient’s 
principal symptom did not correlate with the endoscopic findings. In patients 
with reflux type dyspepsia, the frequent finding was esophagitis. 
Conclusion is that the key symptom did not substantiate in predicting 
the nature and clinically significant findings. The most common finding was 
found to be esophagitis. Empirical therapeutic test with anti ulcer regimen 
can be considered before  the endoscopy. 
 Delaney et al. studied the cost-effectiveness of an earlier endoscopy 
weighed with routine management in dyspeptic patients, who were above the 
age of 50 years. If the cost of upper gastrointestinal endoscopy is low then it 
was found to be cost effective. 
         According to Harding SM et al; the patients who presented with 
aspiration and extraesophageal(pulmonary), regurgitation was found to be 
the prominent one. 
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      According to Hewson EG et al; the patients who presented with chest 
pain like angina had GERD. The hints that suggested that the pain is 
esophageal origin rather than cardiac were  
` Accompanied esophageal symptoms 
` Pain aggravated by food and in supine position 
` Pain that lasted for days without cardiac deterioration 
` Pain relieved by antacids. 
 According to Singh S et al it was tough to distinguish between 
coronary angina and esophageal problem, because many had associated 
problems. 
      According to Brzana RJ and small PK non specific upper 
gastrointestinal symptoms like dyspepsia, nausea, bloating and indigestion 
may be present in patients with GERD. 
        According to Fisher MJ et al singultus and hiccups could be symptoms 
of GERD. 
Some may have water brash, filling of mouth by clear and salty fluid and this 
is attributed to secondary hypersalivation due to acid reflux. 
        According to Mays EE et al pulmonary conditions particularly asthma 
associated with GERD.  
         In United States of America about four million people have peptic 
ulcer disease either duodenal or gastric and about 3,00,000 fresh cases are 
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confirmed every year.  American males have life time risk for developing 
ulcer disease is around 10% and females have 4%. 
       With the complete review of literature and studies the patients who 
had dyspepsia are given reassurance by doing endoscopy and some required 
drug therapy, however the time limit for the reassurance is not very sure. 
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ANATOMY 
ESOPHAGUS: 
The esophagus, a soft muscular tube, allows food to pass between the 
pharynx and the stomach. It is about 25-30cm in length. The esophagus is a 
midline structure anterior to the spine and posterior to the trachea. From its 
origin at the cricoid cartilage in the neck opposite the fifth to sixth cervical 
vertebra, it passes into the thorax at the level of the sternal notch and travels 
caudally within the chest in the posterior mediastinum. It terminates in the 
abdomen at the esophagogastric junction opposite the twelfth thoracic 
vertebra. The esophageal hiatus of the diaphragm is at the level of the tenth 
thoracic vertebra. 
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Anatomy of esophagus 
Anatomically esophagus is divided into three parts: 
 • Cervical 
• Thoracic 
• Abdominal 
 
 
Function divides the esophagus according to its differing forms of motility
into the following three zones  
  According to differing forms of motility (functionally) esophagus is
divided into three zones: 
11 
 
• Upper esophageal sphincter (UES) 
• Esophageal body 
• Lower esophageal sphincter (LES). 
UPPER ESOPHAGEAL SPHINCTER (UES). 
         The high-pressure zone at the inlet of the esophagus is considered as
UES.  Anatomically it marks the end of a complex configuration of muscles
that begin in the larynx and posterior pharynx and end in the neck. The
pharyngeal constrictor muscles are three consecutive muscles that begin at
the base of the palate and end at the crest of the esophagus. The superior and
middle pharyngeal constrictor muscles, as well as the oblique, transverse, 
and posterior cricoarytenoid muscles, are immediately proximal to the UES
and serve to anchor the pharynx and the larynx to structures in the mouth
and palate. These muscles also aid in deglutition and speech, but are not
responsible for the high pressures noted in the UES. The inferior pharyngeal
constrictor muscle is the final bridge between the pharyngeal and
esophageal musculature. 
ESOPHAGEAL  LAYERS: 
        The esophagus is comprised of two proper layers: the mucosa and the 
muscularis propria. It is distinguished from the other layers of the
alimentary tract by its lack of a serosa. The mucosa is the innermost layer
and consists of squamous epithelium for most of its course. The distal 1 to 2
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cm of esophageal mucosa transitions to cardiac mucosa or junctional 
columnar epithelium at a point known as the Z-line. Within the mucosa, 
there are four distinct layers 
1. Epithelium 
2. Basement membrane 
3. Lamina propria, and  
4. Muscularis mucosae. 
HISTOLOGY: 
     
         Enveloping the mucosa, directly abutting the submucosa, is the
muscularis propria. Below the cricopharyngeus muscle, the esophagus is
composed of two concentric muscle bundles: an inner circular and outer
longitudinal. Both layers of the upper third of the esophagus are striated, 
whereas the layers of the lower two thirds are smooth muscle. The circular
muscles are an extension of the cricopharyngeus muscle and traverse
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through the thoracic cavity into the abdomen, where they become the
middle circular muscles of the lesser curvature of the stomach. The collar of 
Helvetius marks the transition of the circular muscles of the esophagus to
oblique muscles of the stomach at the incisura (cardiac notch). Between the
layers of esophageal muscle is a thin septum comprising connective tissue, 
blood vessels and an interconnected network of ganglia known as
Auerbach's plexus. Enshrouding the inner circular layer, the longitudinal
muscles of the esophagus begin at the cricoid cartilage and extend into the
abdomen, where they join the longitudinal musculature of the cardia of the 
stomach. The esophagus is then wrapped by a layer of fibroalveolar
adventitia. 
ESOPHAGEAL CONSTRICTIONS: 
         The esophageal silhouette resembles an hourglass. There are three
distinct areas of narrowing that contribute to its shape. Measuring 14 mm in 
diameter, the cricopharyngeus muscle is the narrowest point of the
gastrointestinal tract and marks the superior-most portion of the hourglass-
shaped esophagus. Occurring just below the carina, where the left main-
stem bronchus and aorta abut the esophagus, the bronchoaortic constriction
at the level of the 4th thoracic vertebra creates the center narrowing and
measures 15 to 17 mm. Finally, the diaphragmatic constriction, measuring
16 to 19 mm, marks the inferior portion of the hourglass and occurs where 
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            The final phase of esophageal bolus transit occurs through the LES. 
Although this is not a true sphincter, there is a distinct high-pressure zone 
that measures 2 to 5 cm in length and generates a resting pressure of 6 to 26 
mm Hg. The LES is located both in the chest and the abdomen. A minimum 
total length of 2 cm, with at least 1 cm of intra-abdominal length, is required 
for normal LES function. The transition from the intrathoracic to the intra-
abdominal sphincter is noted on a manometric tracing and known as the 
respiratory inversion point (RIP). At this point, the pressure of the esophagus 
changes from negative to positive with inspiration and positive to negative 
with expiration.  
Peristaltic contractions alone do not generate enough force to open up 
the LES. Vagal-mediated relaxation of the LES occurs 1.5 to 2.5 seconds 
after pharyngeal swallowing and lasts 4 to 6 seconds. This flawlessly timed 
relaxation is needed to allow efficient transport of a food bolus out of the 
esophagus and into the stomach. A post-relaxation contraction of the LES 
the esophagus passes through the diaphragm. Between these three distinct
areas of anatomic constriction are two areas of dilation known as the
superior and inferior dilations. Within these areas, the esophagus resumes 
the normal diameter for an adult and measures about 2.5 cm.  
LOWER ESOPHAGEAL SPHINCTER (LES) 
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occurs after the peristaltic wave has passed through the esophagus, allowing 
the LES to return to its baseline pressure, re-establishing a barrier to reflux.  
STOMACH 
Stomach  is the most dilated part of the alimentary tract, extending 
from the cardiac end to the pyloric end. The stomach is sub-divided into; 
1. Fundus 
2. Body 
3. Pyloric Antrum 
4. Pyloric Canal 
Fundus is the part which rises above the level of cardiac end of the 
stomach. Body is that portion situated between the fundus and the level of 
incisura angularis in the  lesser curvature of the stomach. 
The pyloric part is situated below the body and consists of: 
1. Pyloric antrum 
2. Pyloric canal 
It is in the pyloric antrum where Helicobacter pylori is most frequently 
colonized.  
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Anatomy of stomach 
Stomach wall has four basic layers:  
1. Mucous membrane 
2. Sub mucosa 
3. Muscular layer 
4. Serosa 
 
 
 
 
 
 
 
 
 
 HIS
    
antr
dise
Mu
(rug
pro
the 
sec
dip
thic
lub
TOLOG
The H
um and i
ase. 
cous mem
It is sm
ae) whic
minent to
antrum. T
rete mucu
s into the 
k mucus 
ricant and
Y 
elicobacte
s importa
brane: 
ooth and
h disappe
wards the
he lining
s and are 
lamina pr
layer, sec
 protects t
r pylori 
nt in relev
 soft. To 
ar when 
 body an
 epitheliu
called “su
opria to f
reted from
he stoma
17 
colonizes 
ance to i
the naked
stomach i
d greater 
m is a si
rface mu
orm gastr
 surface 
ch against
in the mu
ts possibl
 eye, it a
s distend
curvature
ngle layer
cous cells
ic pits. Th
mucous c
 its own a
cous lay
e etiology
ppears as
ed. These
 and are 
 of colum
”. This su
e mucosa
ells. The 
cid and en
 
er of the 
 of pepti
 numerou
 rugae ar
less appa
nar cells
rface epit
 is covere
mucus ac
zymes. 
gastric 
c ulcer 
s folds 
e most 
rent in 
 which 
helium 
d by a 
ts as a 
18 
 
Damage to mucus layer exposes the stomach to gastric acid and active 
gastric enzymes and this is the basis of “Leaking Roof” hypothesis in the 
aetiology of peptic ulcers. 
Gastric glands are three types: 
1)  Cardiac glands 
2)  Main gastric glands 
3)  Pyloric glands 
 
Different cells in gastric glands 
1. Cardiac glands: 
 These are either simple tubular or tubulo-alveolar type confined to 
small area near the opening of oesophagus. They contain mainly mucus 
secreting cells. 
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2. Main gastric glands: 
They are present in the fundus and body of the stomach and they open into 
gastric  
pits. They contain the following cells.  
a. Chief cells: They are numerous in the basal parts of the glands. They 
secrete digestive enzymes like pepsin. 
b. Parietal cells (Oxyntic cells): They are numerous in the upper part of 
the  gland. They are responsible for the secretion of hydrochloric acid  
and intrinsic factor. 
c. Mucous neck cells: They are present near the upper end of the gland 
and  secrete mucous. Their secretions are different from that of the  
surface  mucous cells. 
d. Endocrine cells: These include somatostatin secreting D-cells and 
histamine secreting enterochromaffin-like cells. These are scattered 
throughout the glands. 
e. Gastrin secreting cells (G-cells): Although small in number, they play 
a  vital physiological role. They occur either singly or in small 
clusters in the mid to deep sections of antral glands. They contain 
basilar cytoplasm densely packed with gastrin containing secretory 
granules. The apical or luminal surface of the G-cells is narrowed into 
small microvilli, which are thought to contain the receptors 
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responsible for the aminoacid and peptide stimulation for gastrin 
release. 
f. Undifferentiated cells: These are cells whose functions are not exactly 
known hence termed as undifferentiated cells. 
3. Pyloric glands: 
 These are present in the antrum and pylorus. These extensively coiled 
glands are composed of endocrine, mucous and parietal cells. Mucous cells 
predominate in these glands. 
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PHYSIOLOGY 
 The gastric glands secrete about 2.5litres of gastric juice daily. The 
juice contains cations: Na+,K+, Mg2+,H+ Anions Cl-,HPO42-,SO42-, Pepsins, 
Lipase, Mucus and Intrinsic factor. Parietal cells of gastric glands secrete 
hydrochloric acid and intrinsic factor. Hydrochloric acid provides necessary 
pH for pepsin to start digestion of protein and also stimulates the secretion of 
bile and pancreatic juice. The mucosa of stomach is protected by various 
factors which includes bicarbonate ions secreted by surface mucous cells, 
surface mucus, mucosal blood flow, epithelial regenerative capacity and 
elaboration of prostaglandin. The mucosal protection reinforced by surface 
cell’s membrane potential and tight junctions stop the back diffusion of 
hydrogen ions and thereby protecting the epithelial damage.  
Helicobacter pylori colonizes the mucus layer of the stomach which 
provides the ecological niche in the antrum, which is conducive for its 
habitations. The breakdown of mucus layer and damage to surface epithelial 
cells are the basis of ‘Leaking roof’ hypothesis of the pathogenesis of 
Helicobacter pylori.  
Regulation of gastric secretion: 
 Gastric motility and secretion are regulated by neural and hormonal 
mechanisms 
a) The neural component: It comprises of; 
1. Local autonomic reflexes involving cholinergic neurons.  
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2. Impulses from the CNS by the way of Vagus nerves. 
b) The hormonal component: It involves various gastro intestinal hormones 
like gastrin, cholecystokinin and secretin. 
Secretion of gastric juice has three interconnected phases: 
1. Cephalic phase 
2. Gastric phase 
3. Intestinal phase 
Cephalic phase: 
 Cephalic phase of gastric acid secretion acts by stimulating the vagal 
centre via the hypothalamus. Parietal and Chief cells are affected by direct 
cholinergic stimulation. 
Gastric phase: 
 It starts by food entering and distending the stomach. Local and 
vasovagal  distention reflexes stimulate the acid secretion of the stomach. 
Gastrin is released from the specialised ‘G’ cells of the antrum of stomach in 
response to food in the stomach and gastric distention. Gastrin then 
stimulates the acid secretion by the parietal cells in the body of the stomach. 
Intestinal phase: 
 Gastric secretion is stimulated by food and its digestive products in the 
intestine. This may be due to stimulation of neuro-receptors and release of 
intestinal gastrin. In contrast acidification of the duodenum and the antrum 
results in inhibition of further acid secretion. This may be due to vagal 
inhibition or release of secretin or CCK-PZ (cholecystokininpancreozymin). 
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HISTORY & DEVELOPMENT OF ENDOSCOPY 
As early as the 19th Century, attempts were been made to examine the 
interior of the upper  GIT  by reflecting light in to the body cavities through 
a hollow cylinder, but it was not until Thomas Edison’s invention of the 
incandescent light bulb that it became possible in the late 1870’s to perform 
rigid endoscopy. 
Nevertheless progressively smaller lamps were developed that allowed 
insertion into the stomach through rigid endoscopes, but the nature of the 
light made it impossible to perform long or complex studies due to 
overheating of the instruments. In addition the inability to adapt rigid 
instruments to the curvatures of the bowel permitted only limited 
examination of the upper GI tract. 
These procedures were mostly performed by surgeons, such as the 19th 
Century Polish surgeon Johann Von Mikulicz-Radecki. 
The era of flexible endoscopy began with the introduction of the semi 
rigid gastroscope by R.Schindler in 1936 through work developed in 
collaboration with the German physician Georg Wolf. The way to the 
development of a flexible fiberscope was paved by Baird’s demonstration in 
1928 that light and images could be transmitted through a single glass or 
quartz fiber. 
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In 1950’s when Van Heel in the Netherlands and H.Hopkins and 
N.S.Kapany in England working independently, developed usable flexible 
glass fiber bundles that could transmit light across relatively long distance 
and into the body cavities.      
The next phase of development took place in Ann Arbor at the 
University of Michigan, Physicians H.M.Pollard and Basil Hirschowitz , 
C.Wilbur Peters in   collaboration with Physics students Lawrence Curtis, 
designed the first clinically usable, completely flexible endoscope. 
Hirschowitz and Curtis started working on this concept in 1955 by 
developing an instrument composed of a bundle of individual glass fibres 
that was in theoretical  capable of transmitting light as well as images. 
Along the way, then encountered numerous problems such as fiber 
“Crosstalk”, which differed the light, making interpretation of the images 
impossible. This led to the invention of a glass coating for the fibres for 
insulation and to the development of fiber scope. 
The first controllable tip gastroscope was developed in 1962 and in 
contrast to the most landmark inventions, was first applied clinically and 
then found an industrial application in the examination of  jet engines. 
After trying the flexible gastroscope on himself, Hirschowitz first used 
it in a patient with a bleeding duodenal ulcer in February 1957. The 
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diagnosis was successfully established, and the patient underwent operation 
based on Hirschowitz observations. 
The first commercially produced fiberoptic endoscope made by 
American cystoscope makers Inc, Norwalk, CT. was first used in 1961 and 
the results were published in the Lancet in may of that year. 
Once the development and wide spread use of fiberoptic upper GI 
endoscope became a  routine practice, the therapeutic potential was 
established. Experimental studies, such as those by  W.D.Blackwood, 
S.Silivis, J.P.Papp, C.Sugawa and others demonstrated the feasibility and 
safety of endoscopic haemostasis. 
This has paved the way for the use of endoscopes as vehicle for 
numerous accessories so that today endoscopic surgery include methods of 
haemostasis, excision, ablation, dilatation, decompression, sclerosis and 
foreign body removal. 
INSTRUMENTATION 
Flexible endoscope come in a variety of diameter and lengths, either 
direct- viewing or video. The primary endoscope used for upper GI 
endoscopy is a zero degree, forward viewing endoscope, where as 
duodenoscope  visualizes  the GI tract at 90º to the shaft. Side viewing 
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endoscope is primarily used in the duodenum to visualise the ampulla of 
Vater, but they may also be used in the stomach. 
All endoscopes are either video or fibreoptic and all have a control 
head. In the fiberoptic units, an eye piece is present for either direct 
visualization  or for video attachment. 
The shaft of the endoscope is flexible, especially at the distal tip, 
which has deflection capabilities ranging from 90-240 in the up/down 
position and 100 in right or left directions. The diameter of the insertion tube 
can range between 5.5mm to the distal tip to 11mm for a therapeutic 
endoscope. The diameter of insertion tube for  duodenoscope ranges between 
11.5 to 12.5mm. 
The controls for maneuvering the deflection tip are located on the 
control head with a large inner knob producing up or down deflection and 
the smaller outer knob producing a left or right deflection. Two depressable 
buttons are located adjacent to these deflection knobs. When pressed the top 
button produces suction that may be necessary during the examination. The 
lower button serves two additional functions. Air insufflations occurs by 
simple placement of a finger over the button without applying pressure. 
When this button is depressed a small amount of water is released from the 
tip of the endoscope that is useful for cleaning the tip during the examination 
if it becomes dirty. 
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In the video endoscope, video control buttons on the top of the control 
head are used to freeze an image on the video screen or to save the image for 
printing. 
The flexible shaft is usually 110-120cms in length. This endoscope 
contain a working channel that varies between 2mm (paediatric endoscope) 
to 3.7mm                         (therapeutic endoscope). On the other hand the 
instrument channel in the duodenoscope varies from 3.2-4.2mm. 
 Biopsy forceps, cytology brushes, or other diagnostic instruments are 
passed through the accessory channel. A double lumen therapeutic 
endoscope is also available for more advanced therapeutic endoscopy. 
The flexible endoscope is connected to a light source that is either 
300W Xenon arc lamp or a halogen- tungsten lamp. In addition, air and 
water pumps for insufflations, suction and irrigation are connected to the 
endoscope via the light source unit and controlled using the control buttons. 
If a video monitor is being used, this is also connected to the 
endoscope through the light source. 
Proper hand positioning and manipulation of the flexible endoscope is 
key to perform  an efficient examination. Most endoscopists will hold the 
control head of the endoscope in the left hand, with the thumb on the 
up/down knob and the index and middle finger on the suction and air/water 
button. The thumb & index finger are then used to control the deflection tip 
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during examination. The right hand of the endoscopist is used to hold the 
flexible shaft for insertion, withdraw and rotation during the examination. 
       
 
 Parts of the endoscope    
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UPPER GASTROINTESTINAL ENDOSCOPY 
PROCEDURE: 
PRINCIPLES:  Upper GI endoscopy plays a dominant role in the 
examination of  the upper GI tract. It provides both direct & complete 
visualization  of the  area and direct access for tissue sampling and/or 
therapeutic intervention. This should be mastered  by any clinician with a 
special interest in diseases of the  esophagus, stomach and duodenum. 
 
PATIENT PREPARATION: 
The procedure is explained to  patient in simple terms. During the 
clinical evaluation , allergies, current medication and previous medical 
history are reviewed, the need for antibiotic prophylaxis is assessed. 
The patient should fast over night before the procedure. Out patients 
should be accompanied, particularly if  intra venous sedation is to be used. 
Having a calm & relaxed patient avoids to some extent the need for 
sedation. A tense patient should not be submitted to endoscopy under simple 
topical anaesthesia. Proper sedation dictates  the use of pulse oximetry and 
ECG. 
 A Lignocain gargle or spray is used for topical anaesthesia of the 
pharynx and hypopharynx. When needed, adequate sedation may be 
obtained with benzodiazepines (diazepam, midazolam). Pethedine 
hydrochloride may be added for relaxation and analgesia. This medication 
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should be administered slowly in small doses until the desired level of 
sedation is obtained. 
TECHNIQUE 
INTRODUCTION OF THE ENDOSCOPE: 
The patient lies in the left lateral decubitus position. Following 
appropriate topical anaesthesia, a mouth piece is postioned between upper 
and lower teeth. Endoscope is advanced, taking care to stay on the midline 
and at the interface between the tongue and hypopharyngeal mucosa. 
Tongue, uvula, epiglottis and cricoarytenoid cartilages are seen. Passing 
beside the midline, the cricoarytenoid cartilages are passed and the tip of the 
endoscope stops on the cricopharyngeus. Gentle local pressure while asking 
the patient to swallow allows the tip of the endoscope to pass into the 
cervical esophagus. 
EXAMINATION OF ESOPHAGUS: 
The instrument is advanced under direct vision, with the tip of the 
endoscope always in the centerof the lumen. Using optimal insufflation 
keeps the lumen of the esophagus well distended. 
First hand inspection is important, because no trauma has caused by 
the manipulation or passage of the instrument. 
Two rules should always be followed: 
1. Endoscope must advanced with clear vision of the central lumen. 
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2. If direct vision is obscured or there are any doubts, the endoscope 
should be withdrawn. 
Land marks distal to cricopharyngeal sphincter are extra luminal 
compression of left main bronchus, aortic arch and pulsations of left heart in 
the distal half. 
The gastro-esophageal mucosal junction is usually identified at 38-
40cms from the incisors. This junction is usually serrated and readily 
identified by the color difference between the esophageal and gastric 
mucosa, called as Z line. 
The position of  the  esophageal hiatus in the diaphragm is identified 
by asking the patient to inhale deeply, the diaphragmatic hiatus during 
inspiration creates an imprint on the esophageal and gastric wall. The 
position of both the hiatus and the mucosal junction are recorded in order to 
document the possibility of a hernia or of a columnar lined esophagus. 
 
PASSAGE IN TO THE STOMACH:           
     Gastro-esophageal junction should be observed for closed or widely 
patulous. Passage in to the gastric lumen is usually a simple manoeuvre that 
occurs without resistance. 
On entering the stomach, it becomes distended with air and this often 
causes discomfort to the patient. By dipping the end of the endoscope 
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slightly down and towards the left, a view of greater curvature and of the 
posterior wall is obtained. 
 Aspiration of all retained liquid is done to reduce the risk of 
aspiration & to allow proper examination of the stomach. A rotation 
movement of the tip of the instrument allows examination of the anterior and 
posterior walls of the body of the stomach. The lesser curvature down to  the 
angulus and the greater curvature are viewed by the same position motion. 
The most proximal part of  both curvatures are better examined when using 
the J maneuver. 
 By rotating and angulating the tip, endoscope is advanced to assess the 
antrum. Prepyloric and pyloric ring observed directly, the passage through 
the pylorus being done under direct vision. When the pylorus yields, 
complete assessment of the first part of the duodenum is done as far as the 
superior duodenal angle. 
 While the tip of the endoscope lies along the distal lesser curvature 
and while the stomach is distended, rotation of the instrument is 
accomplished towards the greater curvature, complete 180 degree upwards 
angulation of the endoscope tip completes the  J manoeuvre. 
The endoscope is pulled back while the stomach is distended, 
swinging of the retroflexed tip allows proper visualization of the stomach. 
Simultaneous rotation of the endoscope gives excellent view of the lesser 
curvature from the cardia to angulus. 
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  After straightening the tip endoscope is gently pulled back examining 
the esophagus again. 
Patients are encouraged to avoid drinking or eating for approximately 
30mins after the procedure. 
 
ENDOSCOPIC BIOPSY 
Typical lesions routinely evaluated by biopsy are esophageal 
strictures, mass lesions, gastroduodenal ulcers, gastroduodenitis and polyps. 
Diagnostic yield increases when multiple specimens are taken of any 
suspicious lesion, if one suspects a malignancy, six biopsy specimens and 
cytology will increase the diagnostic accuracy to better than 90-95%.Lesions 
arousing suspicion for being varices should not be biopsied, as this can lead 
to significant bleeding. 
           The biopsy forceps is negotiated into the specified channel and after 
seeing the entry of forceps through the endoscope, the mouth of the forceps 
opened and introduced into the mucosa, closed and retrieved immediately 
taking the desired specimen. Biopsy forceps containing a spike can be used 
to obtain multiple specimens without having to remove it from the 
endoscope. 
Biopsies for gastric ulcers should typically be taken in all four 
quadrants and at the base of the ulcer. The transition zone between the ulcer 
and surrounding mucosa is the area that most likely contains increased 
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mitotic activity in malignant ulcers and therefore biopsy of this region 
improves diagnostic yield. 
Biopsies of submucosal masses can have limited yield because the 
submucosal location is not easily reached. To increase yield several biopsies 
should be taken. Caution is the rule – because the area can become weakened 
and be at risk for perforation. 
 Esophageal stricture, which demonstrate dysplasia or malignant 
transformation should be biopsied. Polyps in the stomach or duodenum can 
be cancerous and should be sampled, either hot or cold biopsy forceps can 
remove diminutive polyps less than 5mm in diameter. Whereas a snare is 
best for larger polyps. The snare is placed at the base of a pedunculated 
polyp, and the polyp is removed in piecemeal fashion. 
Japanese investigators have developed technique for lesion removal 
where by a suction apparatus is passed through the endoscope and lesion is 
grasped with suction. A snare is then placed around the base of the lesion & 
closed tightly and removal of the specimen is possible. If significant 
bleeding results, standard coagulation technique can be employed. 
 
 
 
 
35 
 
PROGRESS OF INTRAGASTRIC OBSERVATION THROUGH THE 
FIBEROSCOPE: 
1. Simplification of the technique of intragastric observation based on 
direct vision. 
2. Elimination of blind spots. 
3. Regulation of various endoscopic conditions. 
4. Advance in observing fine changes through close up observation. 
5. Improvement of recording ability by aiming recording photography 
equipment. 
6. Revolutionizing the technique of biopsy on direct vision through 
the use of fiberscope. 
7. Progress in diagnosing cancer cells by viewing cells according to 
the direct vision method with the fiberscope. 
8. Precise observation through the application of supplemental 
techniques, such as washing the lesion and applying a pigment 
solution.. 
 
DYSPEPSIA: Definition and prevalence 
       Dyspepsia (Dys – difficult, Pepse- digestion) is chronic or recurrent pain 
or discomfprt in upper abdomen. Discomfort here refers to mild pain, upper 
abdominal fullness and early satiety. It can be accompanied by bloating, 
belching, nausea and heart burns. When patients have dyspeptic symptoms, 
36 
 
but no underlying disease is found, the patient is said to have functional or 
idiopathic or non-ulcer dyspepsia.  
Classification:  
            Classification of dyspepsia is based on the symptoms of the patient 
¾ Ulcer type – upper abdominal pain 
¾ Dysmotility type – unpleasant or troublesome non-painful 
sensation in the upper abdomen which might be associated with 
upper abdominal fullness, early satiety, bloatedness or nausea. 
¾ Reflux type 
¾ unclassified 
 
  40% of our general population suffers from dyspeptic symptoms, of 
which 5% get General practitioner consultation and 1% have their 
endoscopic study done. In patients undergoing endoscopy, 40% have 
functional dyspepsia, 40% have GERD and 13% have some form of ulcer. 
Features which suggest serious underlying diseases are: 
• Age more than 55 years 
• Family history of  upper GI malignancy 
• Weight loss(unexplained) 
• Upper GI  bleeding 
• Pain during swallowing 
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• Unexplained Anemia due to iron deficiency 
• Vomiting which is persistent 
• Lymphadenopathy 
• Icterus 
 
ETIOLOGY: 
Etiology can be broadly classified into 2 main groups 
• Structural abnormalities. 
• Functional (Non ulcer) dyspepsia. 
STRUCTURAL ABNORMALTIES: 
• Hiatus hernia. 
• Gastro-esophageal reflux disease (GERD). 
• Barrett’s esophagus. 
• Peptic ulcer disease. 
• Esophageal, gastric and duodenal cancer. 
Hiatus hernia: 
A hiatus hernia occurs when part of the stomach moves up in to the 
chest through a defect in the diaphragm. It is a common problem occurring 
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in 10% of people and the hernia rarely causes symptoms on its own. The 
presence of a hiatus hernia can cause weakness of the lower esophageal 
sphincter and this in turn can cause reflux of the acidic stomach contents into 
the esophagus. This causes the sensation of heartburn and patients with a 
hiatus hernia are more prone to heartburn than those without this defect. 
Nevertheless it is important to emphasise that not all patients with hiatus 
hernia have heartburn and some patients with heartburn do not have a hiatus 
hernia. 
GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD): 
Gastro-esophageal reflux may occur when the pressure of the high-
pressure zone in the distal esophagus is too low to prevent gastric contents 
from entering the esophagus or when a sphincter with normal pressure 
undergoes spontaneous relaxation, not associated with a peristaltic wave in 
the body of the esophagus. GERD is often associated with a hiatus hernia. 
      The most common presentation of patients with GERD is a long-
standing heartburn and a shorter history of regurgitation. Heartburn, when 
typical, is a very reliable symptom. Heartburn is confined to the epigastric 
and retrosternal areas. It is identified as a caustic or stinging sensation. It 
does not radiate to the back and is not characteristically described as a 
pressure sensation. 
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BARRETT’S ESOPHAGUS: 
 It is metaplastic changes in the mucosa of the oesophagus as a result 
of gastroesophageal reflux disease .  squamous  epithelium in lower end of 
oesophagus is replaced by columnar epithelium. The endoscopic picture of 
barrett’s metaplasia will be tongue like projection into the mucosa of 
oesophagus. 
TYPES: 
 (1)Based on length 
¾ Long segment –metaplasia more than 3 cm 
¾ Short segment- metaplasia less than 3 cm 
(2)Histological types 
¾ Gastric type 
¾ Intestinal type  
¾ Junctional type 
    The diseased columnar epithelium is more prone for malignant 
transformation. Regular endoscopic surveillance is essential for early 
detection of malignant transformation. 
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PEPTIC ULCER DISEASE (PUD) 
Ulcer is caused by acid peptic digestion of the mucosa to variable 
depth either in mucosa containing acid secreting cells or in other sites. Peptic 
ulcer extends through the muscularis mucosa, an erosion is superficial to the 
muscularis mucosa. Although the name suggests an association with pepsin, 
it is the acid which is important for the occurrence of peptic ulcer. May be 
acute ulcers which are shallow and multiple or chronic which are single, 
deep and scirrhous.  
Common sites: 
1. 1st part of duodenum 
2. Lesser curve of stomach 
3. Prepyloric and pyloric channel         
 Gastric ulcer: Seen commonly in late middle age and the incidence 
increases with age. Sex incidence is found to be equal. 
Duodenal ulcer: Most common in middle age, more common in males. Male 
to female ratio was found to be 3:1. 10 - 20% of patients with a gastric ulcer 
may have concomitant duodenal ulcer. 
 Etiology 
1. Helicobacter pylori infection 
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2. Endocrine – a) Zollinger-Ellison syndrome b) Cushings syndrome 
c)Parathyroid tumour - hypercalcemia  
3. Genetic:  cases with blood group ‘O’ 
4. Drugs :  NSAIDS, aspirin, steroids  
5. Smoking: a) Predispose to ulcer formation b)Increases the relapse rate 
after treatment. 
6. Alcohol 
7. Diet:  irregular diet, spicy food and excessive intake of coffee and tea 
provoke the formation of peptic ulcer. 
8. Emotional factors: anxiety, stress  have always been incriminated to 
cause peptic ulcer.  
Pathogenesis: 
1. Loss of mucosal defense with hyperacidity 
2. Gastric mucus is an important barrier that protects the gastric mucosa 
from the effects of acid and pepsin.  
3. Decreased bicarbonate concentration  
4. Decreased gastric mucosal prostaglandin production  
5. Acid overproduction is an important factor for causing DU 
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H.pylori:  
It is the most important factor in the development of peptic ulcer. Fifty 
percent of the world's population is infected with H. pylori, a major cause of 
chronic gastritis. Helicobacter also clearly has an etiologic role in the 
development of gastric lymphoma. H.pylori is a small curved, motile, Gram 
negative, microaerophilic rod with multiple polar flagellae. In stomach it 
remains close to the gastric mucus secreting cells. 
It  hydrolyses urea             ammonia             increased gastrin.    
ESOPHAGEAL AND GASTRIC CANCER: 
Gastric and esophageal cancers are rare, accounting annually for 1% 
of deaths from all causes. Gastric cancer is on the decline, while esophageal 
cancer is on the increase. Gastric cancer may be declining because of the 
decreasing prevalence of H.pylori.    
Squamous cell carcinoma and adenocarcinoma account for 95% of  all 
esophageal tumours. Traditionally squamous carcinoma was the most 
frequent lesion but in recent years adenocarcinoma has become the 
predominant disease. Adenocarcinoma of the esophagus is believed to 
originate from columnar metaplasia of the esophagus (Barrett’s esophagus), 
providing a rationale for endoscopic screening of patient’s with Barrett’s 
esophagus. 
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Adenocarcinoma is responsible for over 95% of  all gastric 
malignancies. Half of patients are inoperable at the time of diagnose and few 
of these survive five years, while of  those undergoing operative treatment 
20% are alive after 5 years. Overall 5 year mortality for this disease is 
therefore approximately 90%. Gastric neoplasia is strongly associated with 
H.pylori infection but as the vast majority of  H.pylori infected individuals 
do not develop gastric carcinoma other environmental and genetic factors 
must be important. 
McCarthy Dyspepsia Severity Score 
 In our study the severity of dyspepsia was measured by the score 
proposed by McCarthy. The symptoms evaluated consisted of a 
questionnaire including the frequency and severity of six dyspeptic 
symptoms. 
The symptoms elicited were : 
a. Epigastric pain during day time. 
b. Epigastric pain during night. 
c. Nausea and vomiting. 
d. Anorexia. 
e. Early satiety. 
f. Regurgitation. 
These symptoms were scored for severity and frequency from 0 to 
4 as follows: 
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Frequency grade: 
Frequency Grade Score allotted 
Absent 0 
One per week 1 
Several times per week 2 
 
Severity grade: 
Severity Grade Score allotted 
Absent 0 
Present but not interfering 
with daily work of life 
1 
Present but interfering 
with daily work of life 
2 
 
So one can expect a maximum dyspepsia severity score of 6x4 = 
24 and a minimum score of 6x0 = 0. 
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FUNCTIONAL (NON ULCER) DYSPEPSIA: 
Functional gastrointestinal disorders include a variable combination of 
chronic or recurrent gastrointestinal symptoms that do not appear to be 
explained by structural 
or biochemical abnormalities. These functional disorders include symptoms 
attributed to dysfunction of the oropharynx, esophagus, stomach, small 
bowel, large bowel and  biliary tract. 
          Functional dyspepsia is a heterogeneous syndrome. It can be grouped 
into symptomatic clusters. These ulcer-like dyspepsia (presenting with ulcer 
like symptoms), dysmotility dyspepsia (symptoms include nausea, early 
satiety, bloating, and belching that suggest gastric stasis or small intestinal 
dysmotility), and reflux-like dyspepsia (heartburn or acid regurgitation 
accompanies upper abdominal pain or discomfort). Motility abnormalities 
may be important in a subset of dyspepsia patients but probably do not 
explain the symptoms in the majority.  
 
 
OTHER CAUSES: 
 
1. Biliary or pancreatic diseases. 
2. Metabolic disturbances. 
3. Irritable bowel disease. 
4. Psychiatric diseases. 
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INVESTIGATIONS: 
UPPER GI ENDOSCOPY:  Endoscope is used to  visualize the esophagus, 
stomach and proximal duodenum, if necessary therapeutic procedures can be 
perform. Endoscopy has now become the gold standard test for detecting 
esophageal, gastric and duodenal lesions.  
 
TREATMENT 
1. Reassurance. 
2. Pharmacological treatment: 
a) H 2 receptor blockers- Ranitidine 150mg bid. 
b) Proton pump inhibitors- Omeprazole 20mg, Rabeprazole 20mg, 
Pantoprazole 40mg. 
c) Antacids and alginates- Aluminium hydroxide, Magnesium 
trisilicate, Dimeticone and Peppermint oil. 
d) Prostaglandin analogues- Misoprostol. 
e) Prokinetics- Domperidone and Cisapride. 
SURGICAL PROCEDURES:  
 The discovery of  H.pylori and the development of powerful acid 
suppressive therapy have revolutionized the medical therapy of peptic ulcer 
and gastro-esophageal reflux disease. This has made peptic ulcer surgery 
almost obsolete. Anti-reflux surgery is reserved for selected patients with 
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documented acid reflux whose symptoms are unresponsive to medical 
therapy or who do not wish to take long term PPI treatment. 
 
ANTI-REFLUX SURGERY 
FUNDOPLICATION (OPEN OR LAPROSCOPIC APPROACH) 
a) Nissen fundoplication (360- degree wrap)- most common  anti-reflux 
surgery. 
b) Partial anterior fundoplication. 
c) Partial posterior fundoplication. 
 
ENDOSCOPIC THERAPY: 
Recently, several endoscopic techniques have been developed for the 
treatment of  GERD. These procedures have sparked significant interest 
because they each promise a mechanical treatment for reflux with less 
invasion than a fundoplication. These techniques attempt to augment the 
LES by suturing, radiofrequency energy, Plexiglas injection or 
biocompatible polymer injection. 
 
 
 
48 
 
PEPTIC ULCER SURGERY 
a) TRUNCAL VAGOTOMY: Division of both vagus nerves above the 
hepatic & celiac branches just above the GE junction. This procedure 
is usually combined with drainage procedure. 
                  - Gastrojejunostom 
                 - Pyloroplasty 
b) SELECTIVE VAGOTOMY: Division of both vagus below the hepatic 
& celiac branches.  
c) HIGHLY SELECTIVE VAGOTOMY (HSV):Also called parietal cell 
or proximal gastric vagotomy.  Severs vagal nerve supply to proximal 
2/3rd of the stomach and preserves vagal innervation to the antrum and  
pylorus. Recurrence rate 5 to 10%. 
GASTROJEUJUNOSTOMY:   
 Ananstomosis between proximal jejunum and the most dependant 
portion of greater curvature of the stomach. Anastomosis is antecolic / 
retrocolic, isoperistaltic, no loop, no tension.  
VAGOTOMY + ANTRECTOMY (This procedure has got the lowest 
recurrence rate < 2%).  
`  Billroth I reconstruction (Gastroduodenostomy). 
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`  Roux-en-Y Gastrojejunostomy. 
PYLOROPLASTY: 
a)  Heineke-Mikulicz pyloroplasty  involves a longitudinal incision of 
the pyloric sphincter followed by a transverse closure. Most 
commonly performed pyloroplasty. 
b)  The Finney pyloroplasty  is performed as a gastroduodenostomy 
with division of the pylorus. 
c)  The Jaboulay pyloroplasty differs from the Finney procedure in that 
the pylorus is not transected. 
SURGERY FOR GASTRIC CANCER: 
1.  Endoscopic mucosal resection (EMR). 
2.  Endoscopic submucosal dissection (ESD). 
3.  Wedge resection. 
4.  Open gastrectomy (Partial/ subtotal). 
5.  Laparoscopically assisted gastrectomy (Partial/ subtotal). 
LYMPH NODE LEVELS: 
¾  N 1 : Peri gastric nodes. 
¾  N 2 : Nodes along the vessels. 
¾  N 3 : Distant nodes. 
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EXTENT OF LYMPHADENECTOMY: 
• D 1 Resection: Removal of tumour and N1 nodes. 
• D 2 Resection: Removal of tumour and N1, N2 nodes also removes 
the peritoneal layer over the pancreas and anterior mesocolon. 
SURGERY FOR ESOPHAGEAL CANCER: ESOPHAGECTOMY 
• The Trans-hiatal Approach: The trans-hiatal esophagectomy is 
performed through an upper midline laparotomy and left cervical 
incision.  
• The Ivor Lewis Approach: The trans-abdominal, trans-thoracic 
approach.  
• Three-Field Esophagectomy: This approach is carried out through 
separate laparotomy, right thoracotomy, and cervical incisions. 
• The Thoracoabdominal Approach: The left thoracoabdominal 
approach is probably the least utilized of all approaches to the 
esophagus.  
• The Minimally Invasive Approach: A number of minimally invasive 
techniques to esophagectomy have been described. These include 
laparoscopic, hand-assisted, thoracoscopic and robotic-assisted 
esophagectomy.  
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METHODOLOGY 
 
A prospective clinical study was undertaken at Tirunelveli medical 
college hospital, tirunelveli to know the various upper gastro-intestinal 
endoscopic findings in patients presenting with dyspepsia The study was 
conducted from march 2011 to October 2012.  The patient selection was by 
convenience sampling.   
Dyspeptic patients were included in this study with their informed 
consent. 
A detailed clinically history was elucidated, followed by careful 
clinical examination, which were recorded as per the proforma. All the 
patients included in the study underwent upper gastrointestinal endoscopy 
and the findings were noted.    
 
The inclusion and exclusion criterias were as follows: 
Inclusion criteria: 
1.  Patients above 13 years of age. 
2.  Patients showing symptoms of dyspepsia for 4 or more than 4 weeks. 
3.  Patients with uncomplicated and uninvestigated dyspepsia. 
 Exclusion criteria: 
1.  Patients below 10 years of age. 
2.  Pregnant and lactating women.  
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3.  Patients on proto-pump inhibitors. 
4.  Patients who are known cases of chronic pancreatitis and liver 
disease. 
5.  Patients on NSAID’s for more than one month duration. 
6. Unwilling or unfit patients for endoscopy. 
 
PROCEDURE: 
All the patients in this study group, on inpatient basis underwent upper 
gastro-intestinal endoscopy under topical anesthesia. The patients were 
asked to fast for 12 hours prior to the procedure. Only a few patients were 
given 5-10mg diazepam intravenously for sedation. 
Lignocaine viscous or oral lignocaine sprays were given to the patient 
5-10 minutes before the procedure for the local anaesthetic effect. The upper 
gastro-intestinal endoscopy was conducted with Pentax, flexible, fibreoptic 
endoscope  with patients in left lateral positions. 
  The instrument is advanced under direct vision, with the tip of the 
endoscope in central  lumen. Using the optimal insufflations to keep the 
lumen of the  esophagus well distended. Esophagus was looked for any 
inflammatory changes, growth. The gastro-esophageal mucosal junction was 
identified at 38-40cms from the incisors. (This junction is usually serrated 
and readily identified by the color difference between the esophageal and 
gastric mucosa, called as Z line). 
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The position of  the  esophageal hiatus in the diaphragm is identified 
by asking the patient to inhale deeply, the diaphragmatic hiatus during 
inspiration creates an imprint on the esophageal and gastric wall. The 
position of both the hiatus and the mucosal junction are recorded in order to 
document the possibility of a hernia or of a columnar lined esophagus. 
Gastro-esophageal junction should be observed for closed or widely 
patulous.   On entering the stomach, endoscope slightly down and towards 
the left, a view of greater curvature and of the posterior wall is obtained. 
Aspiration of all retained liquid is done to reduce the risk of aspiration and to 
allow proper examination of the stomach. A rotation movement of the tip of 
the instrument allows examination of the anterior and posterior walls of the 
body of the stomach. The lesser curvature down to the angulus and the 
greater curvature are viewed by the same position motion. The most 
proximal part of  both the curvatures are better examined when using the J 
manoeuvre. Stomach was looked for inflammatory changes, ulcer, growth. 
By rotating and angulating the tip endoscope is advanced to assess the 
antrum. Prepyloric and pyloric ring observed directly, the passage through 
the pylorus being done under direct vision. When the pylorus yields, 
complete assessment of the duodenum is done upto second part. 
Endoscopic biopsies were taken from the abnormal looking area, 
growth and the edge of the ulcer crater depending on the findings.  
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              Biopsy specimens were sent in formalin solution for histopathology 
. Each of the biopsy specimens were fixed in 10% buffered formalin, 
routinely processed to paraffin and 3 μm sections cut.  
 
               Pentax  fiber-optic upper G.I. scope used for the study 
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        Endoscopic biopsy forceps 
 
 Endoscopic view of duodenal ulcer   Endoscopic view of Barrett’s 
esophagus 
 Endoscopic view of Lax LES          
(hiatus hernia)
 Endoscopic biopsy piece being 
removed from the forceps 
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ENDOSCOPIC FINDING IN PATIENTS WITH DYSPEPSIA 
FINDINGS MALE FEMALE TOTAL 
NORMAL STUDY 33 34 67 
OESOPHAGITIS 5 2 7 
GASTRITIS 19 14 33 
DUODENITIS 8 1 9 
GASTRIC ULCER 9 0 9 
DUODENAL ULCER 3 3 6 
GROWTH/MALIGNANCY 3 5 8 
HIATUS HERNIA 1 0 1 
TOTAL 81 59 140 
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DISCUSSION 
 
  A prospective clinico-pathological study entitled “A Clinical study of 
various findings in upper gastro-intestinal endoscopy in patients presenting 
with dyspepsia”  was undertaken in Tirunelveli medical college hospital  to 
study the endoscopic findings of dyspepsia and to detect 
esophagogastroduodenal carcinoma at early stages. 
 After informed consent 140 cases of dyspepsia were included in the 
study and were studied clinically as per the proforma from march 2011 to 
October 2012. All the patients underwent upper gastro-intestinal endoscopy 
and various findings were noted. 
 
CLINICAL PRESENTATION: 
       Out of 140 patients, 112 (78.9%) patients had epigastric pain and 
discomfort as their chief complaint where as nausea and vomiting was 
present in 100 (72.8%) patients. The other complaints were heart burn 85 
(59.9%), food intolerance 70(49.3%), indigestion 65(45.8%) and loss of 
appetite and weight 47(33%). 
       Similar study was conducted by Thomson A B R et al, in which the 
common presenting complaints were upper abdominal pain (34.3%), heart 
burn (24.5%) and acid regurgitation (13.3%), the observations were 
comparable with that of the present study. 
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COMPARISON OF GENDER DISTRIBUTION  
In this study 58% were male patients, 42% were female patients. The 
incidence of different presentations of dyspepsia were common in males 
compared to females. Only the incidence of esophagogastritis was more in 
female patients. 
    The male / female ratio in the studies conducted by Khan N et al – 
2.3:1, Ziauddin- 1.6:1, Mustapha SK et al- 1.1:1 respectively. In these 
studies also the majority of patients were males as observed in our study. 
 In a population based study in Australia, female adults significantly 
out numbered males in most functional gastrointestinal disorders includes 
functional dyspepsia. 
 
COMPARISON OF VARIOUS ENDOSCOPIC FINDINGS: 
       In the present study, clinically significant endoscopic findings were 
observed in 73 patients accounting for 52.14%. Gastritis was by far the most 
common finding (23.6%). The next common findings were duodenitis, and 
gastric ulcer accounting for 6.4% each. 
  The percentage of cases with gastritis in this study was higher than 
that observed in studies by Sarwar et al and Ziauddin. The percentage of 
patients with GERD was nearly equal to that observed by Sarwar et al.  
Table 13. Comparison of common endoscopic findings in various studies  
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SI.No Name of the study Gastritis 
1 Sarwar et al.39 13% 
2 Ziauddin40  18% 
3 Present study 23.6% 
 
COMPARISON OF INCIDENCE OF GASTRIC MALIGNANCIES: 
        In this study there were 8 patients with carcimona stomach accounting 
for 5.7%, among them which 3 were male patients and 5 were female 
patients. Gastric malignancies were common in older age groups. Incidence 
of gastric malignancies observed by various authors are as follows: 
Table 16. Comparison of incidence of gastric malignancies 
Sl.NO NAME OF STUDY PERCENTAGE OF 
GASTRIC MALIGNANCIES 
1 Chadwick P et al.5 1% 
2 Khan N et al.6 3% 
3 Ziauddin40 4% 
4 Present study  5.7% 
  
 The incidence of gastric malignancy in these studies is comparable 
with that observed in the present study. 
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CONCLUSION 
          
            From the present study of “A clinical study of various findings in 
upper gastro-intestinal endoscopy in patients presenting with dyspepsia ”.   
On endoscopic examination gastritis accounted for the majority of the 
cases. Incidence of malignancy in the present study was observed to be 5.7% 
(gastric malignancies). 
Clinically significant endoscopic findings were observed in 52.14% of 
patients with uninvestigated dyspepsia. Most patients presented with a 
complex of three or more dyspeptic symptoms and the symptom profile was 
not predictive of the endoscopic findings.  
Prevalence of large number of inflammatory lesions as a result of 
increased acid production and low incidence of malignancy in the study 
group suggests that the uninvestigated patients with dyspepsia may be 
initially managed medically with acid suppressive therapy.  
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SUMMARY 
 
      A prospective clinico-pathological study was undertaken in 
Tirunelveli medical college hospital to know the various endoscopic findings 
in patients presenting with dyspepsia and early detection of 
oesophagogastroduodenal  malignancy in these patients. 
140 patients  presenting with dyspepsia were evaluated.  
The following were the observations: 
1. Highest prevalence of dyspepsia  in the age group of  30-39years 
2. Most common presenting complaint was epigastric pain and 
discomfort 
3. Dyspepsia was more common in males (58%) when compared to 
females(42%) 
4. Most common endoscopic finding was normal study followed by 
gastritis 
5. Malignancy was diagnosed in 5.7% patients with dyspepsia. 
6. Stomach is the common site of lesion in patients presenting with 
dyspepsia 
7. Gastritis, duodenitis and gastric ulcer is common in males while 
malignancy/growth is more common in females presenting with 
dyspepsia. 
8. Incidence of malignancy increases as the age advances. 
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ANNEXURES 
 
PROFORMA 
 
 
Case serial number: 
 
Name:                                              Age                            Sex: 
 
Occupation: 
 
Complaints: Duration: 
 
History of present illness: 
 
 
a. Pain                                          a) Duration 
                                                    b) Nature 
                                                    c) Site 
                                                    d) Radiation 
                                                    e) Relation to food habits 
                                                    f) Aggravating / Relieving factors 
                                                    g) Periodicity 
 
2.Nausea/ Vomiting                        a) Number 
                                                    b) Contents 
                                                    c) Relation to food 
                                                    d) Relation to pain. 
 
3. Heart burn. 
 
4. Food intolerance. 
 
5. Indigestion. 
 
6. Loss of weight and appetite. 
 
Past History: 
 
 
 
Treatment History:         History of NSAIDs/ Corticosteroid usage 
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Personal History: 
 
   1. Diet:                        Vegetarian/Mixed. 
   2. Appetite:                  Good/Reduced. 
   3. Bowel habits:          Frequency. 
   4. H/o smoking:          Yes/no, duration, number/day. 
   5. H/o alcohol intake:  Yes/no, duration, quantity/day. 
 
General physical examination: 
 
Built:                               Well built/moderately built. 
 
Nourishment:                  Well nourished/poorly nourished 
 
Pallor:                            Present/Absent 
 
Per abdomen:                         Tenderness. 
                                                Deep tender spot. 
                                                Lump/Mass. 
                                                Free fluid. 
                                                Organomegaly. 
 
Other systems:  
 
RS, CVS, CNS. 
 
Clinical Diagnosis: 
 
Endoscopic findings: 
 
 
Other investigations if any: 
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MASTER CHART 
 
S 
No. 
 
PATIENT NAME 
 
AGE
 
SEX
 
OP/IP 
No. 
 
CLINICAL FEATURES 
 
CLINICAL 
DIAGNOSIS
 
ENDOSCOPIC 
FINDINGS 
 
EP
 
HB
 
N/V 
 
FI
 
IDG
 
LW/A
1 VALLITHAI 65 F 53088 
Y Y Y Y Y N 
DYSPEPSIA DU 
2 MANI 28 M 53837 
Y N Y Y N N 
DYSPEPSIA GU 
3 KARTHIK 45 M 55946 
Y Y Y Y Y N 
DYSPEPSIA Ds 
4 RAJASEKAR 25 M 27602 
Y N Y Y N N 
DYSPEPSIA Gs 
5 SUNDARI 52 F 57631 
N Y N N Y Y 
DYSPEPSIA NS 
6 PEER MOHAMED 48 M 7323 
Y Y Y N Y N 
DYSPEPSIA Ds 
7 MASANAM 72 M 35553 
N N Y Y N Y 
DYSPEPSIA GU 
8 PADMAVATHY 66 F 9908 
Y Y N Y Y N 
DYSPEPSIA Gs 
9 PETCHIAMMAL 43 F 4081 
N Y Y N Y Y 
DYSPEPSIA GROWTH 
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10 MOHAMED SALIM 32 M 41124 
Y Y N Y Y N 
DYSPEPSIA GU 
11 PANDIAN 45 M 13718 
Y N N Y Y N 
DYSPEPSIA Es 
12 BANUMATHY 55 F 20023 
N N Y N Y Y 
DYSPEPSIA NS 
13 MADASAMY 59 M 21069 
Y Y N Y Y N 
DYSPEPSIA Es 
14 PERUMAL 55 M 21100 
Y N Y Y Y N 
DYSPEPSIA GU 
15 KRISHNAMMAL 60 F 22692 
Y N Y N N Y 
DYSPEPSIA NS 
16 THAVIDHU 70 M 22037 
Y N Y N Y Y 
DYSPEPSIA NS 
17 GANGADHARAN 50 M 22729 
Y Y Y Y N N 
DYSPEPSIA NS 
18 ESAKKIAMMAL 18 F 23384 
Y N N Y Y N 
DYSPEPSIA NS 
19 SHANMUGATHAI 46 F 81698 
Y N Y Y N N 
DYSPEPSIA NS 
20 MUTHULAKSMI 45 F 22302 
Y Y Y N N N 
DYSPEPSIA NS 
21 POOSAM 30 M 26073 
Y N Y N Y Y 
DYSPEPSIA NS 
22 MUTHU ESAKKI 30 F 23727 
Y N Y N N N 
DYSPEPSIA NS 
23 VEEMAN 46 M 26315 
Y Y N Y Y N 
DYSPEPSIA GU 
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24 ANNATHAI 16 F 27462 
Y N Y Y N N 
DYSPEPSIA NS 
25 RATHINA PAUL 67 M 109317
Y N Y N Y N 
DYSPEPSIA GU 
26 RASOOL BEEVI 36 F 28706 
Y Y Y N N N 
DYSPEPSIA NS 
27 MUNIAPPAN 43 M 112095
Y Y N N Y Y 
DYSPEPSIA NS 
28 PANDI 50 M 29818 
Y Y Y N N N 
DYSPEPSIA NS 
29 EUACHI 27 M 111384
Y N Y Y N N 
DYSPEPSIA NS 
30 KASIPANDI 50 M 30734 
Y Y Y N Y Y 
DYSPEPSIA Gs 
31 SUNDAR 35 M 31249 
Y N Y N Y Y 
DYSPEPSIA NS 
32 SHANMUGAVADIVU 60 F 31722 
Y N N N Y Y 
DYSPEPSIA GROWTH 
33 MARIAPPAN 23 M 27989 
Y Y N Y N N 
DYSPEPSIA Gs 
34 MURUGAN 27 M 31235 
Y Y Y N N Y 
DYSPEPSIA NS 
35 LAKSHMI 55 F 33888 
Y N Y N Y N 
DYSPEPSIA GROWTH 
36 JEEMNA 19 F 35359 
Y Y N N Y N 
DYSPEPSIA NS 
37 SIVAGURUNATHAN 55 M 136352
Y N Y N N Y 
DYSPEPSIA NS 
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38 EASWARAN 52 M 129474
N Y N Y N Y 
DYSPEPSIA NS 
39 SUNDARAJAN 39 M 36736 
N Y Y N Y N 
DYSPEPSIA Gs 
40 SURESH 19 M 38058 
N Y N Y N N 
DYSPEPSIA   NS 
41 AYYADURAI 38 M 37975 
Y N Y N Y N 
DYSPEPSIA GROWTH 
42 SEKAR 34 M 37886 
Y Y Y N N N 
DYSPEPSIA NS 
43 PATTU 60 F 37268 
N Y N Y Y N 
DYSPEPSIA NS 
44 ANGAMMAL 41 F 38554 
N Y Y N Y N 
DYSPEPSIA GROWTH 
45 ESAKKIMUTHU 30 M 38551 
Y N Y Y N N 
DYSPEPSIA NS 
46 LAKSHMI 60 F 140632
Y N Y Y N Y 
DYSPEPSIA NS 
47 THANGARAJ 60 M 38669 
N N Y Y Y N 
DYSPEPSIA Gs 
48 GURUNATHAN 65 M 40079 
Y Y N Y N N 
DYSPEPSIA Gs 
49 SINGARAJ 33 M 39651 
N N Y N Y Y 
DYSPEPSIA NS 
50 RAVI 26 M 47346 
Y Y N Y N N 
DYSPEPSIA Ds 
51 ARUNACHALAM 70 M 41562 
Y Y Y N N N 
DYSPEPSIA GU 
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52 LAKSHMIAMMAL 80 F 42261 
N N Y Y Y Y 
DYSPEPSIA NS 
53 SHAHUL HAMEED 55 M 42483 
Y N N Y Y Y 
DYSPEPSIA DU 
54 YOGAMMAL 60 F 4240 
Y N Y Y N N 
DYSPEPSIA NS 
55 SELVI 43 F 42836 
Y Y Y N N N 
DYSPEPSIA GROWTH 
56 KANAGARAJ 58 M 45537 
Y Y Y N N Y 
DYSPEPSIA GROWTH 
57 MARIAPPAN 57 M 45023 
N Y Y Y N N 
DYSPEPSIA Es 
58 PERIYASAMY 68 M 44988 
Y Y N Y N N 
DYSPEPSIA Gs 
59 PETCHIMUTHU 39 M 47164 
Y Y Y N N N 
DYSPEPSIA NS 
60 ANANDHARAJ 17 M 47380 
N Y Y N Y N 
DYSPEPSIA Gs 
61 JEYARANI 19 F 47429 
N Y Y N Y Y 
DYSPEPSIA NS 
62 KALIMUTHU 36 M 48010 
Y Y N N N Y 
DYSPEPSIA NS 
63 SANKAR 48 M 47933 
Y Y N Y Y N 
DYSPEPSIA Ds 
64 GANAPATHYAMMAL 58 F 49079 
N Y Y N Y N 
DYSPEPSIA Gs 
65 AAMINA BEGAM 37 F 191513
Y Y Y N N N 
DYSPEPSIA NS 
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66 ANNATHAI 40 F 50699 
Y Y N N Y N 
DYSPEPSIA NS 
67 MUTHUKRISHNAN 46 M 51929 
N Y Y N Y N 
DYSPEPSIA NS 
68 MANDIRAN 45 M 51873 
Y N Y Y N N 
DYSPEPSIA NS 
69 AMMAPONNU 45 F 53172 
Y Y N Y N N 
DYSPEPSIA DU 
70 PARAMASIVAM 45 M 52753 
Y N Y Y N N 
DYSPEPSIA NS 
71 KANNAN 30 M 52163 
Y N Y N Y Y 
DYSPEPSIA NS 
72 MARIAPPAN 33 M 56531 
Y Y Y N N Y 
DYSPEPSIA Es 
73 MUTHUPETCHI 30 F 222176
Y Y Y Y N N 
DYSPEPSIA NS 
74 CHANDRAN 31 M 57767 
Y Y Y N N N 
DYSPEPSIA GU 
75 UDHAYAKUMAR 35 M 57803 
Y N Y Y N N 
DYSPEPSIA Ds 
76 ARUMUGAM 43 M 59361 
N Y Y Y N N 
DYSPEPSIA NS 
77 RAJAKUMARI 48 F 61574 
Y Y Y N N N 
DYSPEPSIA Gs 
78 KANDAN 70 M 61047 
Y Y N Y Y N 
DYSPEPSIA NS 
79 MURUGAN 33 M 2046 
Y N N Y Y Y 
DYSPEPSIA NS 
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80 CHELLAPPA 70 M 4154 
Y N Y Y Y N 
DYSPEPSIA Gs 
81 PADMAVATHI 26 F 4273 
N Y Y N Y Y 
DYSPEPSIA NS 
82 RAMALAKSHMI 45 F 3623 
Y Y Y N N N 
DYSPEPSIA NS 
83 RAHMATH NISHA 35 F 4614 
Y N Y Y N Y 
DYSPEPSIA NS 
84 MURUGAN 38 M 4723 
Y N Y Y N N 
DYSPEPSIA Gs 
85 NAGESHWARI 27 F 17665 
Y N Y Y Y Y 
DYSPEPSIA Ds 
86 MARIAPPAN 31 M 2913 
Y N Y N Y Y 
DYSPEPSIA NS 
87 RAMAIAH 65 M 24204 
Y Y Y N N N 
DYSPEPSIA GROWTH 
88 ANITHA 34 F 9150 
Y N Y Y N Y 
DYSPEPSIA Gs 
89 MARIYAM BEEVI 70 F 12130 
N N Y Y Y Y 
DYSPEPSIA Gs 
90 EDWARD 25 M 15681 
Y Y N Y N N 
DYSPEPSIA NS 
91 MARIMUTHU 32 M 53104 
Y Y N Y N N 
DYSPEPSIA Ds 
92 MANIAMMAL 45 F 19183 
N Y Y Y N N 
DYSPEPSIA Es 
93 PUSHPAM 50 F 17297 
Y Y N Y N Y 
DYSPEPSIA NS 
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94 MADASAMY 60 M 19533 
Y Y Y N N N 
DYSPEPSIA DU 
95 SELVIMENAKA 39 F 20966 
N N Y Y Y Y 
DYSPEPSIA Gs 
96 VASANTHI 22 F 24176 
Y Y N Y N N 
DYSPEPSIA Gs 
97 VIGNESHWARAN 30 M 25624 
N Y Y Y N N 
DYSPEPSIA NS 
98 SANTHANAMARI 55 F 32389 
Y Y N Y Y N 
DYSPEPSIA Gs 
99 DEVIKA 25 F 87602 
Y Y N Y N Y 
DYSPEPSIA NS 
100 SIVAGAMI 65 F 35834 
Y Y Y N N N 
DYSPEPSIA NS 
101 SIVAKUMAR 20 M 46749 
Y Y Y N Y N 
DYSPEPSIA NS 
102 MURUGAN 46 M 46813 
Y N Y N Y Y 
DYSPEPSIA GU 
103 PALANIRAJ 42 M 43076 
Y Y Y N Y N 
DYSPEPSIA Ds 
104 ARUMUGASAMY 47 M 160410
Y N Y N Y Y 
DYSPEPSIA NS 
105 VIJAYASHREE 32 F 46612 
Y N Y Y N Y 
DYSPEPSIA NS 
106 CHELLAMMAL 65 F 43431 
N Y Y Y N N 
DYSPEPSIA NS 
107 ESWARAN 63 M 37234 
Y Y Y N N N 
DYSPEPSIA Gs 
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108 PATTAMMAL 50 F 38480 
N Y Y N Y Y 
DYSPEPSIA NS 
109 SENTHIL 32 M 41496 
Y N Y N Y Y 
DYSPEPSIA Ds 
110 KANAGAMANI 45 F 100743
Y Y N Y Y N 
DYSPEPSIA NS 
111 MANIKANDAN 21 M 98236 
Y N Y Y N N 
DYSPEPSIA Gs 
112 GOMATHINAYAGAN 57 M 89856 
Y Y Y N N Y 
DYSPEPSIA NS 
113 ANWAR 36 M 33234 
Y N Y Y N N 
DYSPEPSIA Gs 
114 SARASWATHI 50 F 35240 
N N N N N N 
DYSPEPSIA NS 
115 AMAICHAR 46 F 91225 
Y N Y N Y Y 
DYSPEPSIA Gs 
116 SELVAKUMAR 41 M 19658 
Y Y N Y N Y 
DYSPEPSIA Gs 
117 SORNAMMAL 59 F 19678 
Y N Y N Y Y 
DYSPEPSIA NS 
118 KARUPPAIAH 70 M 22279 
Y Y Y N N N 
DYSPEPSIA NS 
119 BABU 37 M 24718 
Y Y Y N N N 
DYSPEPSIA Gs 
120 SAGUNTHALA 19 F 25537 
Y Y N N Y N 
DYSPEPSIA NS 
121 RAJALAKSHMI 33 F 25488 
Y Y N Y N N 
DYSPEPSIA NS 
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122 MURUGAN 54 M 12443 
N Y Y N Y N 
DYSPEPSIA Gs 
123 PERUMALAMMAL 45 F 122955
Y N Y Y Y N 
DYSPEPSIA Gs 
124 CHELLAMMAL 65 F 12630 
N Y Y Y N N 
DYSPEPSIA Gs 
125 KUMAR 40 M 15947 
Y N Y N Y Y 
DYSPEPSIA NS 
126 MUTHUSAMY 43 M 18033 
Y Y Y N N N 
DYSPEPSIA Gs 
127 MARIMUTHU 32 M 53104 
Y Y Y N N N 
DYSPEPSIA Ds 
128 KANAGA 21 F 54811 
Y Y N N Y N 
DYSPEPSIA Es 
129 JEGANMOHAN 33 M 28419 
N Y Y Y N N 
DYSPEPSIA HH 
130 SUDALAIKANI 65 F 25074 
Y Y N N Y N 
DYSPEPSIA Gs 
131 SHAHUL HAMEED 53 M 94385 
Y Y Y N N N 
DYSPEPSIA Es 
132 ISMAIL MEERA 18 F 9422 
Y N Y Y Y N 
DYSPEPSIA Gs 
133 PERUMAL 53 M 11451 
Y N Y Y N Y 
DYSPEPSIA NS 
134 SULOCHANA 65 F 11284 
N Y N Y N Y 
DYSPEPSIA DU 
135 KANAGAVALLI 24 F 5317 
Y Y N Y N N 
DYSPEPSIA NS 
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136 GANESH 45 M 38557 
Y Y Y N N N 
DYSPEPSIA Gs 
137 MAHARAJA 21 M 6094 
Y N Y N Y N 
DYSPEPSIA Gs 
138 REGITHA 33 M 6467 
Y Y Y N N N 
DYSPEPSIA NS 
139 GNANVELAMMAL 55 F 4462 
Y Y N Y N N 
DYSPEPSIA NS 
140 MAYILAMMAL 30 F 5875 
Y N Y N Y N 
DYSPEPSIA Gs 
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KEY TO MASTER-CHART 
 
OP.NO - Out patient number. 
 
IP NO – In patient number 
 
EP- Epigastric pain. 
 
HB- Heart burn. 
 
N/V- Nausea/ Vomiting. 
 
FI- Food intolerance. 
 
IDG- Indigestion. 
 
L W/A- Loss of Weight/ Appetite. 
 
NS- Normal Study 
 
Es- Esophagitis. 
 
HH- Hiatus hernia. 
 
Gs- Gastritis. 
 
GU- Gastric ulcer.. 
 
Ds- Duodenitis. 
 
DU- Duodenal ulcer. 
 
M- Male. 
 
F- Female. 
 
Y- Yes. 
 
N- No. 
